Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?
The discovery that stem cells isolated from different organs have the ability to differentiate into mature beating cardiomyocytes has fostered considerable interest in developing cellular regenerative therapies to treat cardiac diseases associated with the loss of viable myocardium. Clinical studies...
Saved in:
Main Authors: | Nathalie Rosenblatt-Velin, Suzanne Badoux, Lucas Liaudet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/5961342 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting prognosis using stroke-heart indicator: brain natriuretic peptide in patients with aneurysmal subarachnoid hemorrhage
by: Jionghao Xue, et al.
Published: (2025-01-01) -
Effect of galectin-3 and brain natriuretic peptide levels on echocardiographic parameters of left heart chamber following coronary artery bypass grafting
by: Yulia A. Styazhkina, et al.
Published: (2024-12-01) -
Associates of an Elevated Natriuretic Peptide Level in Stable Heart Failure Patients: Implications for Targeted Management
by: Aftab Jan, et al.
Published: (2013-01-01) -
N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults
by: Ulrike Braisch, et al.
Published: (2022-06-01) -
The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
by: Alberto Palazzuoli, et al.
Published: (2013-01-01)